Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Mar 2008 07:02 AM
RNS
Phase III Trist Study
10 Mar 2008 07:01 AM
RNS
Preliminary Results
29 Feb 2008 11:43 AM
RNS
Total Voting Rights Update
20 Feb 2008 07:00 AM
RNS
Phase III Trist Study
19 Feb 2008 04:22 PM
RNS
Holding(s) in Company
15 Feb 2008 09:05 AM
RNS
Major Interest In Shares
13 Feb 2008 12:15 PM
RNS
Major Interest in Shares
07 Feb 2008 07:00 AM
RNS
Notification of Results
01 Feb 2008 10:40 AM
RNS
Notification of Shares
31 Jan 2008 08:57 AM
RNS
Total Voting Rights
30 Jan 2008 08:00 AM
RNS
Notifcation of Shares
23 Jan 2008 09:16 AM
RNS
Major Interest in Shares
22 Jan 2008 07:00 AM
RNS
Development Milestone
18 Jan 2008 12:53 PM
RNS
Notification of Shares
07 Jan 2008 07:00 AM
RNS
Exclusive License Agreement
18 Dec 2007 01:35 PM
RNS
Interest In Shares
13 Dec 2007 07:00 AM
RNS
Phase I/II Trial
10 Dec 2007 12:28 PM
RNS
Major Interest in Shares
10 Dec 2007 07:00 AM
RNS
Trovax Phase III Trial
05 Dec 2007 01:33 PM
RNS
Scrip's Deal of the year
29 Nov 2007 10:51 AM
RNS
techMARK Award
16 Nov 2007 11:18 AM
RNS
Block Listing
09 Nov 2007 07:00 AM
RNS
Broker Announcement
26 Oct 2007 07:01 AM
RNS
Patent Infringement Dispute
25 Oct 2007 11:27 AM
RNS
Director/PDMR Shareholding
25 Oct 2007 07:01 AM
RNS
Business Update
22 Oct 2007 02:57 PM
RNS
Director Shareholdings
28 Sep 2007 03:25 PM
RNS
Holding(s) in Company
11 Sep 2007 07:00 AM
RNS
Milestone in Trovax
11 Sep 2007 07:00 AM
RNS
Interim Results
31 Aug 2007 03:39 PM
RNS
Holding(s) in Company
31 Aug 2007 10:26 AM
RNS
TVR Update
30 Aug 2007 09:10 AM
RNS
Holding(s) in Company
07 Aug 2007 07:00 AM
RNS
Notice of Results
03 Aug 2007 04:33 PM
RNS
Holding(s) in Company
02 Aug 2007 03:38 PM
RNS
Holding(s) in Company
02 Aug 2007 07:02 AM
RNS
Phase II Clinical Trial Data
31 Jul 2007 03:05 PM
RNS
Total Voting Rights
25 Jul 2007 07:00 AM
RNS
DSMB Interim Analysis-TroVax
06 Jul 2007 07:00 AM
RNS
License Agreement
02 Jul 2007 07:00 AM
RNS
Lentivector Licence
29 Jun 2007 04:17 PM
RNS
Total Voting Rights
28 Jun 2007 12:39 PM
RNS
Holding(s) in Company
28 Jun 2007 12:29 PM
RNS
Notification of Interest
22 Jun 2007 12:43 PM
RNS
Viragen Update
18 Jun 2007 07:01 AM
RNS
Health Care Conference
18 Jun 2007 07:00 AM
RNS
Holding(s) in Company
04 Jun 2007 07:01 AM
RNS
Phase II Trovax data at ASCO
31 May 2007 05:38 PM
RNS
Total Voting Rights Update
29 May 2007 07:01 AM
RNS
ASCO data

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings